GNIPST Bulletin 51.2

7/23/2019 GNIPST Bulletin 51.2

1/24

27-11-2015G

G

N

N

I

I

P

P

S

S

T

T

U

U

L

L

L

L

T

T

I

I

N

N

2

2

1

1

5

5

27th

November, 2015 Volume No.: 51 Issue No.: 02

Vision

TO REACH THE PINNACLE OF GLORY AS A CENTRE OF EXCELLENCE IN TH

FIELD OF PHARMACEUTICAL AND BIOLOGICAL SCIENCES BY KNOWLED

BASED LEARNING AND PRACTICE

ontentsMessage from PRINCIPAL

Editorial board

Historical article

News Update

Knowledge based Article

Disease Related Breaking

News

Upcoming Events

Drugs Update

Campus News

Students Section

Editors Note

Archive

GNIPST Photo Gallery

or your comments/contribution

For

ack-Issues,

ailto:[email protected]

GURU NANAK INSTITUTE OF PHARMACEUTICAL

SCIENCE AND TECHNOLOGY

Website:http://gnipst.ac.in
https://plus.google.com/u/0/photos/111714720327580099858/albums/5897323676427099873?sort=7mailto:[email protected]:[email protected]:[email protected]://plus.google.com/u/0/photos/111714720327580099858/albums/5897323676427099873?sort=7


2/24

27-11-2015

MESSAGE FROM PRINCIPAL

"It can happen. It does happen.

But it can't happen if you quit." Lauren Dane.

We are what we repeatedly do.

Excellence then is not an act, but a habit. Aristotle

It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank t

last years editors and congratulate the newly selected editors for the current year.

Our first consideration is always in the best interest of the students. Our goal is to promote academexcellence and continuous improvement.

I believe that excellence in education is aided by creating a learning environment in which all learners asupported in maximizing their potential and talents. Education needs to focus on personalized learni

and instruction, while promoting an education system that is impartial, universally accessible, and meeti

the needs of all students.

It is of paramount importance that our learners have sufficient motivation and encouragement in order

achieve their aims. We are all very proud of you, our students, and your accomplishments and looforward to watching as you put your mark on the profession in the years ahead.

The call of the time is to progress, not merely to move ahead. Our progressive Management is looki

forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken

this direction and fruits of these efforts will be received by our students in the near future. Our Teacheare committed and dedicated for the development of the institution by imparting their knowledge and pl

the role of facilitator as well as role model to our students.

The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positi

challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holist

needs of our students.

I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of t

opportunities and meet the challenges with purpose and determination.

Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us

this path.

My best wishes to all.

Dr. A. Sengupta

Click here to go at the top

1


3/24

27-11-2015

EDITORIAL BOARD

CHIEF EDITOR DR. ABHIJIT SENGUPTAEDITOR MS. JEENATARA BEGUM

ASSOCIATE EDITOR MR. DIPANJAN MANDAL

HISTORICAL ARTICLE

Ernest Lawrence

Beginnings

Ernest Orlando Lawrence was born on August 8, 1901 into amiddle-class family in the small prairie-town of Canton, South

Dakota, USA. His father was Carl Gustavus Lawrence, thesuperintendent of schools and a history teacher. His mother wasGunda Regina Jacobson, a mathematics teacher. Both were ofNorwegian ancestry.Ernest attended elementary and high school in Canton, except forfour years spent in South Dakotas capital, Pierre. The familymoved to Pierre because his fathers job took them there whenErnest was aged 9 13. Ernest was tall and thin, and he picked upthe nickname skinny, which he didnt mind.The young boy grew up as a seriously knowledgeable radio-ham.He built a shortwave transmitter and shared his enthusiasm forwireless communications with two rather remarkable friends. Onewas his junior brother John, who became one of the founders ofnuclear medicine; the other was Merle Tuve, whose forebears werealso Norwegian, and who became a very eminent physicist.Ernests parents were rather devout members of the LutheranChurch. His mother was vehemently opposed to her son to going

to the state university, fearing he might be led astray there! Heenrolled in medicine at the University of South Dakota inVermillion in 1919 without his mothers knowledge. Although amedical student, his passion for building radio transmitters did notslacken. He approached Lewis Akeley, the Dean of Engineering,about setting up a campus radio station.


2


4/24

27-11-2015

Akeley, who had once been a professor of chemistry and physics,was so impressed by the young radio enthusiasts expertise inelectronics that he persuaded him to forget about premedicalstudies and switch to physical sciences instead. So Ernest majored

in physical science. And he also started South Dakotas first everradio station!Ernest Lawrence graduated at the age of 21 with a bachelorsdegree, then joined his childhood friend Merle Tuve at theUniversity of Minnesota, where he completed a masters degree inphysics in two years. In 1925 he obtained his Ph.D. in physics fromYale University.Ernest Lawrences Contributions to Science

The CyclotronAlpha-particle bombardmentsBy 1929 Lawrence had been an associate professor of physics at theUniversity of California at Berkeley for a year.Until then, physicists had used radioactive elements as a source ofhigh energy particles. Alpha-particles, escaping at high speedsfrom radioactive nuclei, had offered scientists likeErnestRutherford a way to bombard chemical elements with high energy

atom-sized particles. This had led to a number of groundbreakingdiscoveries, including the discoveries of the proton and the atomicnucleus.Particle AcceleratorsIn 1929 Lawrence picked up a copy of a science journal to readduring a particularly tedious meeting he had to attend. The journalincluded a paper by Rolf Widere, one of the pioneers of a newconcept in physics particle accelerators, or atom-smashers.Particle accelerators promised scientists a way of using electricity

to produce atom-sized particles moving at high speeds. Unlikeradioactive sources of particles, the amount of energy carried byparticles from accelerators could be fine-tuned to produce specificresults.


3
http://www.famousscientists.org/ernest-rutherford/http://www.famousscientists.org/ernest-rutherford/http://www.famousscientists.org/ernest-rutherford/http://www.famousscientists.org/ernest-rutherford/


5/24

27-11-2015

This was an especially exciting field, because it seemed certainthat momentous new discoveries would emerge from the use ofaccelerators.Accelerated particles could be crashed into target atoms,

producing debris from which information about the tiny, unseenworld of the atomic nucleus could be obtained. Also, it waspossible that new types of atoms and chemical elements could beproduced.Rolf Widere had envisioned a device in which high voltageswould be used to accelerate particles in a straight line.Miniaturizing an AcceleratorLawrence thought that, if it were to produce very high energy

particles, Wideres device would be too long to fit in a typicallaboratory.And he instantly had his big idea: instead of accelerating particlesin a straight line, he would use electromagnets to accelerate themin a spiral path, gathering ever more speed and energy until theysmashed into their target. His device would be smaller and cheaperthan Wideres.The first cyclotron Lawrence built was only 4 inches (10 cm)across and cost $25. And it worked! It accelerated ions of hydrogen

molecules to an energy of 80,000 electron volts.It is ironic that Lawrences big idea was in low-costminiaturization. Soon enough, he would be the pacesetter in high-cost big science.Missing out on DiscoveriesIn the early 1930s Lawrence and his growing team, althoughmaking great efforts to make new discoveries using theircyclotrons, were not very successful.

They could have discovered transmutation of lithium to helium byproton bombardment, but didnt. This splitting of the atom wasdiscovered in 1932 by John Cockcroft and Ernest Walton, at theUniversity of Cambridge in the UK, for which the pair received the1951 Nobel Prize in physics.


4


6/24

27-11-2015

They could have discovered nuclear fusion, but didnt. This wasdiscovered in 1934 byErnest Rutherford and Mark Oliphant, alsoat the University of Cambridge in the UK. Oliphant used a particleaccelerator to fire deuterium ions at substances such as ammonium

chloride and found he had produced helium-3 and tritium. (In fact,Lawrences team in Berkeley had carried out a similar experimentbut had to Lawrences ultimate considerable embarrassment misinterpreted the results, wrongly believing they had discoveredthat deuterons disintegrate.)

They could have discovered how to synthesize artificial radioactiveelements by alpha-particle bombardment, but didnt. This wasdiscovered in 1934 by theJoliot-Curiesat the Curie Institute in

Paris, France, for which they received the 1935 Nobel Prize inChemistry. Lawrence was particularly dismayed when he heardabout this, because he realized it was something his ownlaboratory could have achieved easily.Cancer Treatments

Lawrences cyclotrons were soon making a difference to peopleslives. In 1921 the American people had raised $100,000 forMarieCurieto purchase a mere 1 gram of radium for research and cancertreatments. Radioactive elements for cancer treatments wereshockingly expensive.With his cyclotron, Lawrence realized he could fine-tune theproduction of radioactive isotopes.In 1934 he saw that sodium-24 could be an ideal, non-toxic sourceof gamma rays for cancer radiotherapy. He used one of hiscyclotrons to convert normal rock salt into sodium-24 by deuteronbombardment. Soon, for about $2 worth of salt and power, he wasmaking the radiotherapy equivalent of radium that had cost

$100,000 in 1921!Lawrence continued his efforts to make radioisotopes for cancertherapy and during this work researchers in his laboratorydiscovered carbon-14, oxygen-15, fluorine-18, and thallium-201.


5
http://www.famousscientists.org/ernest-rutherford/http://www.famousscientists.org/irene-joliot-curie/http://www.famousscientists.org/marie-curie/http://www.famousscientists.org/marie-curie/http://www.famousscientists.org/marie-curie/http://www.famousscientists.org/marie-curie/http://www.famousscientists.org/irene-joliot-curie/http://www.famousscientists.org/ernest-rutherford/


7/24

27-11-2015

Technetium-99m, now used worldwide in tens of millions ofmedical procedures every year, was also discovered in hislaboratory. Technetium-99ms use has saved millions of lives.Keeping it in the Family

In 1936 Lawrence invited his brother, John, from Yale Universitysmedical faculty, to Berkeley to cooperate in trials using thecyclotron and its products in medical treatments. The result washuge success, to the extent that John Lawrence is now known asthe father of nuclear medicine.In 1937 Lawrences mother was diagnosed with inoperable cancerand given just a few months to live. Ernest and John decided toattack her tumor using an incredibly powerful x-ray machine that

Ernest and his team had built and installed at the University ofCalifornias medical school. The result was that his mother wascompletely cured. She actually went on to outlive Ernest.Cyclotrons and Cancer TodayIn addition to producing radioisotopes for cancer treatments,cyclotrons are still in use today producing proton beams, whichyield neutron beams, which are used to attack cancers directly.The Nobel Prize

Ernest Lawrence was awarded the Nobel Prize in Physics in 1939for his invention of the cyclotron and the discoveries made with it.He and his team had conquered a huge number of colossalengineering problems to achieve their results.Ever Bigger Science and the Bomb

By 1940 Lawrence was planning a 184-inch cyclotron, whichneeded 4500 tons of magnets. The Rockefeller Foundation put upover a million dollars to get the project started. Lawrencesresearch was growing fast in scale and ambition. It had become big

science.It is a testament to Lawrences energy and persuasive skills that hewas able find funding. He was helped by the fact that governmentsaround the world were becoming increasingly interested inreleasing the enormous amounts of energy scientists had realizedwere present in the atomic nucleus.


6


8/24

27-11-2015

With the worlds most advanced accelerators and the discovery in1940 of plutonium using the Berkeley 60-inch cyclotron, Lawrencewas destined to play a leading role in the Manhattan Project theproject that built the worlds first nuclear weapon and would push

science to ever greater scales of operation.Lawrence developed a new device, the calutron, to separateisotopes of uranium. The calutron was a hybrid of the cyclotronand a mass spectrometer. Calutrons were employed to produce theuranium-235 that was used in the Little Boy atomic bomb droppedon Hiroshima in August 1945.The largest cyclotron Lawrence built for research purposes wasthe 184-inch (4.67 meter) cyclotron completed in 1942. Protons

could be accelerated to energies in excess of 100 MeV.Today, the age of big science that began with Lawrence marchesonward. Ever bigger, ever more expensive, ever more powerfuldevices continue to reveal the extent and depth of the subatomicworld.In 2015, CERNs Large Hadron Collider operated in a circulartunnel almost 17 miles (27,000 meters) long underneathSwitzerland. Particle energies had reached 6.5 TeV about 65,000times more powerful than Lawrences 1942 device.

Some Personal Details and the EndLawrence married Mary Kimberly Blumer in May 1932; thedaughter of the Dean of Yales Medical School, she was alwaysknown as Molly. Molly had a bachelors degree in bacteriology andmet her future husband on a blind date. The couple had sixchildren.Ernest Lawrence died following surgery for intestinal problems atthe age of 57 on August 27, 1958, in a hospital in Palo Alto,

California.Less than a month after his death, the University of Californiarenamed two of the universitys nuclear research laboratories in hishonor: the Lawrence Livermore National Laboratory and theLawrence Berkeley National Laboratory. Today both continue asworld-leading research centers.


7


9/24

27-11-2015

Three years after his death, element 103 was discovered, producedfor the first time in a particle accelerator at the Lawrence BerkeleyNational Laboratory. The element was named lawrencium inhonor of the man who had made its discovery possible.

NEWS UPDATE

Even the elderly can recover from a severe

traumatic brain injury: (27thNovember, 2015)Even patients over the age of 75 may recover from severe traumaticbrain injury, suggests new research. This is the first study todescribe the results of surgically treated elderly patients with

acute subdural hematomas.Novel therapy aims to use patients' own immune

cells to protect cells that produce insulin: (25th

November, 2015)Patients experienced no serious adverse reactions after receivinginfusions of as many as 2.6 billion cells that had been speciallyselected to protect the body's ability to produce insulin, reportscientists and physicians at the end of a trial focused on a new type1 diabetes immunotherapy approach.

Discovery could open door to frozen preservation

of tissues, whole organs: (25thNovember, 2015)A new approach to 'vitrification,' or ice-free cryopreservation, hasbeen discovered, which could ultimately allow a much wider use ofextreme cold to preserve tissues and even organs for later use.

New strategy discovered for treating arthritis:

(25thNovember, 2015)Arthritis patients could one day benefit from a novel form ofmedicine, according to researchers. Their early study indicates thatarthritic cartilage, previously thought to be impenetrable to


8


10/24

27-11-2015

therapies, could be treated by a patient's own 'microvesicles' thatare able to travel into cartilage cells and deliver therapeutic agents.

Two-thirds of studies on 'psychosocial'

treatments fail to declare conflicts of interest:(25thNovember, 2015)The creators of commercially sold counseling programsincreasingly profit from public health services across the world.However, a new study on the evidence basis for some of the marketleaders reveals that serious conflicts of interest across the majorityof the research go habitually undisclosed.

Certain factors may help identify patients for

surgical procedure for obstructive sleep apnea:(25thNovember, 2015)Patients with more severe obstructive sleep apnea are more likelyto receive greater benefit from the surgical procedure known asmaxillomandibular advancement, according to a recent study.

Amblyopia, not strabismus, identified as key

contributor to slow reading in school-age

children: (25thNovember, 2015)Children with amblyopia, commonly known as 'lazy eye,' may haveimpaired ocular motor function. This can result in difficulties inactivities for which sequential eye movements are important, suchas reading. A new study determined that children with amblyopiaread more slowly than children with normal vision or withstrabismus alone.

Lower availability of omega-3 fatty acids in thebody associated with bipolar disorder: (24th

November, 2015)People with bipolar disorder have lower levels of certain omega-3fatty acids that cross the blood-brain barrier compared to thosewho do not, according to researchers.


9


11/24

27-11-2015

Visual stress could be a symptom of Chronic

Fatigue Syndrome, research suggests: (24th

November, 2015)Vision-related abnormalities have been identified that may helpclinicians diagnose Chronic Fatigue Syndrome (CFS). CFS, alsoknown as Myalgic Encephalomyelitis (ME), is a condition thatcauses persistent exhaustion that affects everyday life and doesn'tgo away with sleep or rest. Diagnosis of the condition is difficult asits symptoms are similar to other illnesses.

Exploring the causes of cancer: (23rdNovember,

2015)Cells communicate with other cells in our bodies by sending andreceiving signals. Cancer can occur when these signals are'dysregulated' and abnormal cells grow out of control, scientistshave determined.

Biologists characterize new form of mRNA

regulation: (23rdNovember, 2015)Biologists used material from both humans and plants to examine

chemical modifications to messenger RNA, or mRNA, finding thatthe modifications appear to play a significant role in the process bywhich mRNAs either survive and become translated into proteinor are targeted for degradation.

For detail mail to editor

KNOWLEDGE BASED ARTICLE

Stem cell study paves the way for patienttherapies

The research -- which focused on human embryonic stem cells --paves the way for clinical trials of cell therapies to treat conditions


10
mailto:[email protected]:[email protected]


12/24

27-11-2015

such as Parkinson's disease, age-related degeneration of the eyesand spinal cord injury.The study also sets out a cost-effective approach for monitoringthe quality of stem cell-based products and newly emerging cell

therapies.Stem cells have the potential to become any of the varied cell typesfound in the body. Researchers have been investigating how theymay be used to repair or replace damaged tissues in patients.However, because the cells continuously produce copies ofthemselves, there are concerns that they may acquire geneticabnormalities that could lead to cancer.Scientists at the University of Edinburgh investigated the genetic

make-up of human stem cells that have been grown in thelaboratory from cells found in the early embryo.The 25 cell lines tested were all 'clinical-grade' -- which meansthey meet the strict quality requirements for cell lines earmarkedfor use as therapies.The team at the Medical Research Council Centre for RegenerativeMedicine analysed each of the cell lines using a technique calledmolecular karyotyping, which is a highly sensitive method ofdetecting genetic abnormalities.

More than half of the cell lines carried large but stable geneticdifferences, the researchers found. However, these changes are alsopresent in healthy people without significant consequences,reflecting the genetic diversity of the human population.They found that a small number of the cell lines acquired geneticproblems if they were grown in the laboratory for too long.Researchers say this highlights the need for continued genetictesting of emerging stem cell-based products to ensure they are

suitable for use in patients.The study is published in the journal Scientific Reports. It was fundedby the Medical Research Council and The Cure Parkinson's Trust.More than three-quarters of the global clinical-grade embryonicstem cell lines have been established the UK. The stem cell linesanalysed in the study were established for clinical use by the


11


13/24

27-11-2015

Universities of Sheffield and Manchester, King's College London,and Roslin Cells, a company that specialises in the production ofclinical-grade cells for use in therapies.Dr Tilo Kunath, Senior Research Fellow at the Medical Research

Council Centre for Regenerative Medicine, University ofEdinburgh, said: "This is the largest study of therapeutically usefulstem cells to date and shows that we are in a good place to pushforward new cell therapies into clinical trials."Dr Paul Colville-Nash, Programme Manager for Stem Cell,Developmental Biology and Regenerative Medicine at the MRC,said: "Collating a library of stem cells that we understand andknow are fit for use in patients is vitally important if these are to

be routinely used in the clinic. This work complements that of theUK Regenerative Medicine Platform that is seeking to address thekey knowledge gaps needed to accelerate development, and ensurethe safety and efficacy, of emerging stem cell therapies."

Jeenatara BegumAssistant Professor

GNIPST

DISEASE RELATED BREAKING NEWS

Cholera United Republic of Tanzania: (26th

November, 2015)

The Ministry of Health and Social Welfare (MOHSW) ofTanzania has notified WHO of additional laboratory-confirmed

cases of cholera. Across the country, at least 9,871 cases have beenreported, including 150 deaths.Read more


12
http://www.who.int/csr/don/26-november-2015-cholera-tanzania/en/http://www.who.int/csr/don/26-november-2015-cholera-tanzania/en/


14/24

27-11-2015

UPCOMING EVENTS

National Seminar on Recent Advances in Natural ProductsChemistry for Drug Discovery will be held on 28th to 29thNovember, 2015 at Department of Chemistry, Netaji SubhashMahavidhylaya, Udaipur, Tripura.

National Conference on Medicinal Chemistry Perspective in DrugDiscovery and Therapy will be held on 3rd December, 2015 atPacific College of Pharmacy, Pacific University, Udaipur,Rajasthan.

DRUGS UPDATES

FDA Approves Opdivo to Treat Metastatic Renal

Cell Carcinoma: (23rdNovember, 2015)The U.S. Food and Drug Administration

approved Opdivo (nivolumab) to treat patients with advanced

(metastatic)renal cell carcinoma, a form of kidney cancer, who

have received a certain type of prior therapy.

Read more

CAMPUS NEWS

Swarangam:On 9th November, 2015 GNIPST organized the post puja and preKalipuja celebration programme Swarangam.

National Science Day 2015:On 7thNovember 2015, GNIPST organized a National Seminer on

Current Innovation in Biotechnology for Human Welfare, on the

occasion of Science day 2015 on the theme of Science for NationBuilding. Sponsored by West Bengal State Council of Science &

Technology, Catalysed & Supported by National Council for

Science, Technology & communication, DST, New Delhi.

Winners of Intracollege Football Tournament:


13
http://d/Jeenat/Bulletin%2034.3_1/New%20Folder/UPCOMING%20EVENTS.docxhttp://www.drugs.com/opdivo.htmlhttp://www.drugs.com/cdi/nivolumab.htmlhttp://www.drugs.com/condition/renal-cell-carcinoma.htmlhttp://www.drugs.com/newdrugs/fda-approves-opdivo-metastatic-renal-cell-carcinoma-4302.htmlhttp://www.drugs.com/newdrugs/fda-approves-opdivo-metastatic-renal-cell-carcinoma-4302.htmlhttp://www.drugs.com/condition/renal-cell-carcinoma.htmlhttp://www.drugs.com/cdi/nivolumab.htmlhttp://www.drugs.com/opdivo.htmlhttp://d/Jeenat/Bulletin%2034.3_1/New%20Folder/UPCOMING%20EVENTS.docx


15/24

27-11-2015

Congratulations to B.Pharm final year for their victory inIntracollege Football Tournament.

Intracollege Football Tournament:On 9thOctober and 10thOctober, 2015 GNIPST has organized the

Intracollege Football Tournament.

EN BIOLET:On 5thand 6thOctober, 2015 seminar was held on EN-BIOLET byStone India Ltd.

INDOOR BATTLE 2015On 24th September, 2015 GNIPST organised the Indoor games(Table Tennis, Carrom, Chess for both Boys and Girls) Indoor

Battle 2015.Congratulations to all winners and participants.The Winners are:Table Tennis (for Boys):1st: Soumen Dhara (M.Pharm, 2ndyear [Pharmacology])2nd: Ratul Banduri (B.Pharm, 3rdyear)3rd: Sneham Sen (B.Pharm, 3rdyear)Table Tennis (for Girls):

1

st

: Sweta Saha (B.Sc [BT], 3

rd

year)2nd: Moutan Roy (B.Pharm, 2ndyear)Carrom (for Boys):1st: Sk. Sajjat Ali (B.Pharm, 4th year) and Sk. Abdul Aslam(B.Pharm, 3rdyear)2nd: Sourabh Saha (B.Pharm, 4th year) and Rajib Singha Roy(B.Pharm, 4thyear)3rd: Arnab Banerjee (M.Pharm, 2ndyear [Pharmaceutics])and Achinta Banerjee (M.Pharm, 2ndyear [Pharmaceutics])

Carrom (for Girls):1st: Sreyashee Mitra (B.Pharm 4th year) and Rituparna Das(B.Pharm 4thyear)2nd: Rinita DasBhowmik (B.H.M, 1styear) and Tania Datta (B.H.M,1styear)


14


16/24

27-11-2015

3rd: Sushmita Sen (D.Pharm, 2ndyear) and Keya Das (D.Pharm, 2ndyear)Chess (for Boys):1st: Sayantan Dutta (B.Pharm, 3rdyear)

2nd: Tanmoy Das Biswas (B.Pharm 4thyear)3rd: Sourabh Saha (B.Pharm 4thyear)Chess (for Girls):1st: Rituparna Das (B.Pharm 4thyear)2nd: Suchetana Dutta (B.Pharm 4thyear)3rd: Krishnakali Basu (B.Pharm 4thyear)

SAGAR DUTTA MEDICAL COLLEGE FEST-ASTERICA 2015WINNER:

The students of GNIPST stood first in the FASHION SHOWcompetition of Sagar Dutta Medical College Fest:Congratulation to the participants-Souvik Ganguly (B.H.M 2ndyear)Riya Taran (B.Pharm 4thyear)Moktar Hossain (B.Pharm 4thyear)Chandrika Saha (B.Pharm 4thyear)Swaranjeet Banik (B.Pharm 4thyear)Sampita Pal (B.Pharm 3rdyear)Ranit Kundu (M.Pharm 1styear)Susmita Kar (B.Pharm 2ndyear)Md. Nadeem Shah (B.Pharm 4thyear)Sreyashee Mitra (B.Pharm 4thyear)Sunanda (M.Pharm 1styear)Best Male Model of ASTERICA 2k15:Souvik Ganguly (B.H.M 2ndyear)Best Female Model of ASTERICA 2k15:

Sampita Pal (B.Pharm 3rdyear)Anchor:Sreejita Roy (B.Sc )Solo Singingcompetition:Sayantan Goswami (B.Pharm 4thyear):winnerArpita (B.Sc) :2ndrunner up


15


17/24

27-11-2015

CARNIVAL OF CANVASS:On 4thSeptember the Students of GNIPST celebrated the freshersparty for Masters degree students.On 4th September the students of GNIPST celebrated Teachers

Day.

ESPERANZA:On 21st August, 2015 the 1st year students of GNIPST werewelcomed in the Freshers Welcome Programme ESPERANZA.

HOMAGE TO FORMER PRESIDENT DR A P J ABDULKALAM:On 31st July, 2015 all the students and teachers of GNIPST paid

their homage for our former president Dr. A P J Abdul Kalam.ALUMNI ASSOCIATION:

GNIPST has been certified by the Alumni Association under theWest Bengal Societies Registration Act, 1961.

FAREWELL PROGRAMME:On 15th May 2015 GNIPST celebrated the farewell programmeSesh Chithi for the final year students of M.Pharm, M.Sc,B.Pharm, B.Sc and BHM.

JIS SAMMAN 2015On 11th May, 2015 GNIPST attended the JIS SAMMAN 2015.

JIS SAMMAN Awards: Best College (Non Engineering):

GNIPST

Best Principal:Dr (Prof.) Avijit Sengupta

Best HOD:Mr. Jaydip Ray

Best Faculty:Mr. Debabrata Ghoshdastidar (Pharmacy)Dr. Swati Chakraborty (Life Sciences)

Best faculty since inception:


16


18/24

27-11-2015

Mr. Jaydip Ray

Best Office Staff:Ms. Jaya Banerjee

Best technical Assistant:

Mr. Somnath Majhi College Blue:

Avik Paul

Highest DGPA of 2014:B.Pharm:Purbali Chakraborty (4th year)Diksha Kumari (3rd year)Aishika Dutta (2nd year)

Sampita Paul (1st year)M.Pharm:Aritra Mukherjee (Pharmaceutical Chemistry)Mounomukhar Bhattacharya (Pharmacology)B.Sc (Biotechnology):Papiya Saha (3rd year)Shomasree Das (2nd year)Ayanita Basak (1st year)

B.Sc (Microbiology):Bonhisikha Chatterjee (3rd year)Riaz Hossain (2nd year)Soumi Chowdhury (1st year)BHM:Bishal Roy (3rd year)Shreyabhanja Chowdhury (2nd year)

Recitation:Udita Majumder

Debate:Srijita RoyPoushali Ganguly

Quiz:


17


19/24

27-11-2015

Arani RayDipayan Nath

Band:Syantan Ghoswami

Anurag GhoshAtanu MondalArka KhamaruRitobroto PaulAbhirup Dasgupta

Fashion:Md. Nadeem ShahKoustav Sarkar

Shaksar SahaAvirup DasguptaRanit KunduNamrata GangulyShreyasee MitraChandrika SahaDebopriya ChatterjeeRiya Taran

Innovative Modeling:Ankit ChowdhuryKartik KoleyMudasar MannaDipan ChaterjeeAbhishek SinghKaustav PalManojit Dutta

SPIRIT JIS 2015On 03th to 05th April, 2015 JIS organised SPIRIT JIS 2015.

GPAT 2015 Result:The following B.Pharm. final year students have qualified, GPAT-2015. We congratulate them all.Diksha Kumari


18


20/24

27-11-2015

Rupanjay BhattacharyaAvik Paul

Xtasy 2015:GNIPST is going to organize the Tech Fest Xtasy 2015 from 30th

March, 2015 to 1st April, 2015.

FINISHING SCHOOL TRAINING PROGRAMME:The FINISHING SCHOOL TRAINING PROGRAMME wasorganized by the Entrepreneurship Development Cell and Training& Placement Cell, GNIPST in collaboration with Indian PharmacyGraduates Association (IPGA), Bengal Branch from 21st Februaryto 11thApril, 2015 at GNIPST Auditorium.

On 21st

February, 2015 the Finishing School Training Programme ofGNIPST was inaugurated by Sri Soumen Mukhopadhyay, DeputyDirector, Drug Control Office, Goutam Kr. Sen, President, IPGA,Mr. Subroto Saha, Asst. Directorate, Drug Control Office, Mr.Ranendra Chakraborty, Sales Manager and Associate Director Dr.Reddys Laboratory.On 28th February, 2015 Dr. D. Roy, Former Deputy DrugController, Mr. Sujoy Chakraborty, divisional Therapy Manager,

Cipla and Mr. Vikranjit Biswas, Senior Manager, Learning &Development, Cipla delivered their valuable lectures in the 2nd dayFINISHING SCHOOL TRAINING PROGRAMME of GNIPST.On 14th March, 2015 Mr. Milindra Bhattacharya, Senior Manager,QA & QC, Emami Ltd. and Mr. Joydev Bhoumik, Manager,Operation, Ranbaxy Laboratory Limited delivered their valuablelectures in the 3rd day FINISHING SCHOOL TRAININGPROGRAMME of GNIPST.On 21st March, 2015 Mr. Tridib Neogi, Associate Vice-President(Quality Assurance), Albert David Ltd. delivered his valuablelectures in the 4th FINISHING SCHOOL TRAININGPROGRAMME of GNIPST.On 28th March, 2015 Dr. Gautam Chaterjee, an Alumni of JadavpurUniversity and presently associated with NIPER delivered his


19


21/24

27-11-2015

valuable lectures in the 5th FINISHING SCHOOL TRAININGPROGRAMME of GNIPST.On 11th April, 2015 the closing ceremony of the FINISHINGSCHOOL TRAINING PROGRAMME was held in GNIPST

Auditorium.

JOBS:All the students of Final Year B. Pharm and M. Pharm are herebyinformed that an interview will be conducted on 23rdMay, 2015 byStandard Pharmaceuticals Ltd. GSK for post: Production, QA, QC.All the students of Final Year B. Pharm and M. Pharm are herebyinformed that an interview will be conducted by GSK for sales and

marketing job.Details given below:

Date: 27.03.2015Time: 09:45 amVenue : GSK Consumer Healthcare Limited, Unit No. 208,

2nd

Floor, Ecospace Campus B (3 B), New Town,Rajarhat, 24 Pgs (N). Kolkata-700156.

THYROCARE provisionally selected 15 students from JIS Group.

Amongst these, 3 students of B. Sc (H) Biotechnology and M. ScBiotechnology have been selected.Ipsita Mondal (M. Sc Biotechnology)Debriti Paul (M. Sc Biotechnology)Debopriya Chatterjee {B. Sc (H) Biotechnology}

The final year students of B.Pharm (31 students) and B.Sc (11students) attended the pooled campus drive of Abbott India Ltd.on 10th March, 2015 at Jadavpur University. Among them 17students have gone through to the final round of this pooledcampus drive and short listed for final selection.

ACHIEVEMENT:

Congratulations to Anurag Chanda, student of B.Pharm final yearwho have got the 1st prize in poster presentation event in Prakriti


20


22/24

27-11-2015

2015 at Department of Agricultural and Food engineering, IIT,Kharagpur.

OTHERS:On 24

th

and 25th

February, 2015 Swamiji of Gourio Math wasdelivered some motivational lectuers in GNIPST.The students of GNIPST participated in the 4

th

Sardar JodhSinghTrophy organised by NIT on 20

th

February, 2015.

On 8th February, 2015 Gnipst celebrated the ReunionprogrammeReminiscence Reloaded 2015.

STUDENTS SECTION

WHO CAN ANSWER FIRST????

What is gatophobia ?

Answer of Previous Issues Image

Study of wine

Congratulation Parag Roy for the correct

answer

Send your thoughts/

Quiz/Puzzles/games/write-ups or any other

contributions for Students Section answ ers

of this Section at

[email protected]

EDITORS NOTE

It is a great pleasure for me to publish the 2nd

issue of 51th

Volume

of GNIPST BULLETIN. All the followers of GNIPST BULLETIN

are able to avail the bulletin through facebook account GNIPST

bulletin I am very much thankful to all the GNIPST members and


21
mailto:[email protected]:[email protected]:[email protected]


23/24

27-11-2015

readers who are giving their valuable comments, encouragements

and supports. I am also thankful to Dr. Abhijit Sengupta, Director

of GNIPST for his valuable advice and encouragement. Special

thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidarand Mr. Soumya Bhattacharya for their kind co-operation and

technical supports. Thank you Mr. Soumya Bhattacharyafor the

questionnaires of the student section. An important part of the

improvement of the bulletin is the contribution of the readers. You

are invited to send in your write ups, notes, critiques or any kind of

contribution for the forthcoming special and regular issue.

ARCHIVE

The general body meeting of APTI, Bengal Branch has been

conducted at GNIPST on 15thJune, 2012. The program started with

a nice presentation by Dr. Pulok Kr. Mukherjee, School of Natural

Products, JU on the skill to write a good manuscript for

publication in impact journals. It was followed by nearly two hour

long discussion among more than thirty participants on different

aspects of pharmacy education. Five nonmember participantsapplied for membership on that very day.

GNIPST is now approved by AICTE and affiliated to WBUT for

conducting the two years post graduate course (M.Pharm)

inPH RM CO LO GY

The approved number of seat is 18.

The number of seats in B.Pharm. has been increased from 60 to

120.

AICTE has sanctioned a release of grant under ResearchPromotion Scheme (RPS) during the financial year 2012-13to

GNIPST as per the details below:

a. Beneficiary Institution: Guru Nanak Institution of Pharmaceutical

Science & Technology.


22


24/24

27-11-2015

b.Principal Investigator:Dr. LopamudraDutta.

c. Grant-in-aid sanctioned:Rs. 16,25000/- only

d.Approved duration: 3 years

e. Title of the project: Screening and identification of potentialmedicinal plant of Purulia & Bankura districts of West Bengal

with respect to diseases such as diabetes, rheumatism, Jaundice,

hypertension and developing biotechnological tools for enhancing

bioactive molecules in these plants.

Activity Clubs of GNIPST:

Name of Club Member FacultySPORTS Mr. Debabrata GhoshDastidarLITERARY AND PAINTING Ms. Jeenatara BegumSCIENCE AND INNOVATIVEMODELLING

Mr. Samrat Bose

ECO Ms. Sumana RoySOCIAL SERVICES Dr. Asis BalaPHOTOGRAPHY Ms. Sanchari Bhattacharya

CULTURAL Ms. Priyanka RayDEBATE AND EXTEMPORE Mr. Soumya Bhattacharya


GNIPST Bulletin 51.2

Documents

Transcript of GNIPST Bulletin 51.2